Skip to content

CRN announces lineup for inaugural Innovation Exchange at CONVERGENCE ‘24 meeting

Table of Contents

WASHINGTON – The Council for Responsible Nutrition (CRN) has revealed the topics selected for its very first Innovation Exchange event.

The event was developed to showcase new research discoveries, technologies, and ingredients in the context of CRN’s annual industry gathering, which provides a unique intimacy of scale and collegiality of community among attendees focused closely on dietary supplements.

Innovation Exchange is part of CRN’s annual CONVERGENCE ‘24 taking place in Salt Lake City Oct. 9–11 (crnusa.org/2024events). Innovation Exchange will kick off the afternoon of Oct. 9 following Science in Session and WellComms, with seven 25-minute presentations selected by a steering committee of experts from Jamieson Wellness, Nestlé Health Science, Pharmavite, Plexus Worldwide, and USANA, including:

Sugar Reduction with Allulose—The Holy Grail of Sugar Replacement. Presented by Anderson Advanced Ingredients, Richard J. Johnson, M.D., physician, researcher, and author, will share evidence supporting allulose as the ideal sugar replacement, discussing mechanisms of action and key clinical findings. He’ll cover allulose in relation to GLP-1 and as a calorie restriction memetic and exercise and anti-aging mimetic.

Prenatal Nutrition Innovation: How Balchem's Portfolio Supports Mom and Baby. Presented by Balchem, Eric Ciappio, Ph.D., senior manager, nutrition science, and Lauren Eisen senior strategic marketing manager, will highlight the latest advancements in prenatal nutrition. featuring cutting-edge, research-backed ingredients including unique forms of iron, choline, and folate. These innovative ingredients offer benefits including superior bioavailability, enhanced tolerability, and lasting health benefits for advancing prenatal nutrition and supporting the health of future generations.

Next Gen of Supplementation from Broccoli. Presented by Brassica Protection Products’ (BPP) nutritional biochemist Jed W. Fahey, Sc.D., recently retired Johns Hopkins Medical School faculty member. He will share his excitement about the development of BPP’s newest market entry, a glucoraphanin-rich broccoli seed extract offering enhanced bioavailability. He’ll discuss benefits of the novel, standardized extract, co-delivered with a stable and potent source of myrosinase.

Lactoferrin's Role in Beauty from Within and Women's Health. Presented by FrieslandCampina, Urszula Kudla, Ph.D., global manager, technical sales and applications, will discuss emerging science supporting multiple health benefits of the functional ingredient lactoferrin. Dr. Kudla will provide an overview of lactoferrin’s role in iron absorption and in skin elasticity, texture, and moisture, with opportunities for innovation in beauty from within and women’s health product formulation.

CurQ+, a Next-Gen Curcumin Formulation to Support Joint and Bone Health. Presented by Stratum Nutrition, Karen Posey, Ph.D., will present compelling findings on Stratum’s curQ+, a novel formulation of curcumin. This session will highlight how curQ+ supports cellular health in cartilage by promoting the normal cellular export processes. Dr. Posey will discuss the role of curQ+ in maintaining cartilage integrity and supporting bone growth through its effects on cellular function.

Innovative Approaches to Sleep Health: The Science and Benefits of RelaxPLX. Presented by SuanNutra, Marcos López, business development director, will discuss the company’s innovative solutions for sleep health, emphasizing the science supporting its key ingredient, RelaxPLX lemon verbena extract. Mr. López will share how the ingredient is backed by advanced research, the product development process, and specific opportunities and challenges within the sleep health sector.

Transforming Mental Wellness: The Future of Biotics with AI/ML and GABA Probiotic, LP815. Presented by Verb Biotics, Diane Alexander, Ph.D., director of sales and Camille Delebecque, Ph.D., head of biotechnology, will share how advancements in artificial intelligence (AI) and machine learning (ML) are driving the transformative impact of biotics on mental wellness. They will focus on the innovative psychobiotic GABA Probiotic, LP815, specifically designed to support mental health and backed by clinical trial results.

“CRN’s inaugural Innovation Exchange represents the latest advancements in nutrition science, down to the ingredient/nutrient level,” said Susan Hazels Mitmesser, Ph.D., chief science officer at Pharmavite, who served on the Innovation Exchange steering committee and will moderate the event. “The selected proposals demonstrate the emerging science that companies are investing in to help develop innovative solutions for products that address consumers’ health needs and wellness goals.”

The Innovation Exchange will be open to all registered event attendees on site for CRN’s annual events including Science in Session or WellComms, and the main CONVERGENCE. Attendees will have the opportunity to connect with representatives from the presenting companies at on-site tabletop booths, as well.

Learn more at crnusa.org/2024events

Comments

Latest